NantHealth Inc. (NH)
NASDAQ: NH
· Real-Time Price · USD
1.35
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
NantHealth Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 64.27M | 68.44M | 67.68M | 67M | 65.53M | 63.21M | 62.8M | 62.6M | 65.21M | 69.67M | 71.16M |
Cost of Revenue | 24.93M | 26.44M | 28.09M | 28.84M | 28.38M | 28.23M | 27.89M | 27.76M | 28.02M | 28.76M | 29.07M |
Gross Profit | 39.34M | 41.99M | 39.59M | 38.16M | 37.15M | 34.98M | 34.91M | 34.84M | 37.19M | 40.9M | 42.09M |
Operating Income | -44.44M | -48.09M | -51.07M | -51.33M | -50.22M | -47.13M | -44.01M | -40.9M | -35.8M | -31.56M | -29.78M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -70.64M | -69.37M | -64.33M | -68.1M | -58.77M | -55.98M | -58.89M | -58.47M | -61.78M | -61.85M | -94.66M |
Net Income | -70.37M | -69.04M | -64.07M | -67.78M | -58.82M | -56.01M | -58.8M | -58.26M | -61.66M | -61.81M | -94.8M |
Selling & General & Admin | 54.98M | 62.84M | 64.23M | 62.5M | 60.36M | 56.75M | 54.57M | 52.09M | 48.98M | 48.45M | 48.61M |
Research & Development | 19.36M | 23.3M | 22.5M | 23.05M | 23.07M | 21.42M | 20.41M | 19.71M | 19.34M | 19.37M | 18.74M |
Other Expenses | 3.05M | 2.96M | 5.6M | 4.62M | 2.41M | 5.18M | -513K | -3.09M | -10.14M | -13.15M | -16.85M |
Operating Expenses | 77.39M | 89.09M | 90.66M | 89.49M | 87.38M | 82.11M | 78.92M | 75.74M | 72.26M | 71.73M | 71.14M |
Interest Expense | -1.82M | 6.55M | 14.82M | 14.12M | 13.97M | 14.03M | 14.36M | 14.48M | 15.85M | 17.14M | 18.11M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.75M | -12.75M | -12.75M |
Cost & Expenses | 102.32M | 115.54M | 118.75M | 118.33M | 115.76M | 110.34M | 106.81M | 103.5M | 100.28M | 100.5M | 100.21M |
Income Tax Expense | -264K | -328K | -263K | -317K | 57K | 90K | 125K | 97K | 294K | 348K | 346K |
Shares Outstanding (Basic) | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.68M | 7.63M | 7.42M |
Shares Outstanding (Diluted) | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.7M | 7.68M | 7.63M | 7.42M |
EPS (Basic) | -9.14 | -8.96 | -8.31 | -8.79 | -7.63 | -7.27 | -7.65 | -7.66 | -8.2 | -8.28 | -12.82 |
EPS (Diluted) | -9.14 | -8.96 | -8.31 | -8.79 | -7.63 | -7.27 | -7.65 | -7.66 | -8.2 | -8.28 | -12.82 |
EBITDA | -42.5M | -38.13M | -34.58M | -37.98M | -31.9M | -36.83M | -40.23M | -41.14M | -42.36M | -36.42M | -34.63M |
EBIT | -72.46M | -62.82M | -49.51M | -53.98M | -44.8M | -41.95M | -44.52M | -43.99M | -45.93M | -44.71M | -76.55M |
Depreciation & Amortization | 2.02M | 10.08M | 13.85M | 10.7M | 16.9M | 12.78M | 12.8M | 12.59M | 12.59M | 9.65M | 6.61M |